Skip to main content
    E

    Eli Lilly and Company (LLY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $1433.55
    -9.95 (-0.69%)

    Market Cap: $1.29T

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Eli Lilly and Company (LLY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Eli Lilly and Company are Johnson & Johnson (JNJ), AbbVie (ABBV) and Merck & Company (MRK). Eli Lilly and Company trades at 44.9x earnings, against a median of 19.9x for the 9 of these companies with a P/E. By market cap, Eli Lilly and Company is the largest of the 13 companies on this page, at $1.29T.

    Peer Comparison

    LLY's ROIC of 30.7% is above the peer median of 13.5%, and its revenue growth of 38.6% is above the median of 6.3%. Its dividend yield is below the peer median of 2.67%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Eli Lilly and Company (LLY)$1.29T44.9x14.8x31.9%30.7%38.6%0.48%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Peer median$230.18B19.9x5.0x15.9%13.5%6.3%2.67%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Eli Lilly and Company, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    Johnson & Johnson (JNJ)
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors

    Frequently Asked Questions About LLY

    Who are Eli Lilly and Company's main competitors?

    The companies most similar to Eli Lilly and Company include Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Company (MRK), Pfizer (PFE) and Bristol-Myers Squibb Company (BMY), listed from the closest match.

    Who is Eli Lilly and Company's biggest competitor?

    Johnson & Johnson (JNJ) is both the largest of the similar companies at $687.89B and the closest match by business profile, size, sector and industry.

    How does LLY stock compare with its competitors?

    LLY's P/E is 44.9x against a peer median of 19.9x; its P/S is 14.8x against a peer median of 5.0x; its net margin is 31.9% against a peer median of 15.9%.

    Which of Eli Lilly and Company's competitors pays a higher dividend?

    Eli Lilly and Company has a forward dividend yield of 0.48%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD), Johnson & Johnson (JNJ) and AstraZeneca (AZN) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Eli Lilly and Company bigger than its competitors?

    Yes. Eli Lilly and Company is the largest by market cap among the 13 companies on this page, at $1.29T.